Ali Sak
Impact in
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- DNA Repair Mechanisms 8
- Chromatin Remodeling and Cancer 3
- Cancer therapeutics and mechanisms 2
- Oncology 7
- Cancer-related Molecular Pathways 3
- Co-authors
- Martin Stuschke (21 shared papers)Michael Groneberg (14 shared papers)Christoph Pöttgen (4 shared papers)Rainer Kehlbach (1 shared paper)Markus Löbrich (1 shared paper)Shaomeng Wang (1 shared paper)Mahmoud Toulany (1 shared paper)H. Peter Rodemann (1 shared paper)
- Journals
- International Journal of Radiation Biology (9 papers)Scientific Reports (3 papers)Molecular Cancer Therapeutics (2 papers)Cancers (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Ali Sak
32 papers receiving 908 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 197
- Oncology 251
- Molecular Biology 574
- Radiology, Nuclear Medicine and Imaging 125
- Genetics 48
Countries citing papers authored by Ali Sak
This map shows the geographic impact of Ali Sak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Sak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Sak more than expected).
Fields of papers citing papers by Ali Sak
This network shows the impact of papers produced by Ali Sak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Sak. The network helps show where Ali Sak may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Sak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 156 | |
| 2 | 2007 | 96 | |
| 3 | 2010 | 93 | |
| 4 | 2005 | 54 | |
| 5 | 2019 | 48 | |
| 6 | Selective inactivation of DNA-dependent protein kinase with antisense oligodeoxynucleotides: consequences for the rejoining of radiation-induced DNA double-strand breaks and radiosensitivity of human cancer cell lines. | 2002 | 45 |
| 7 | 2003 | 40 | |
| 8 | 1995 | 33 | |
| 9 | 2015 | 31 | |
| 10 | 2000 | 30 | |
| 11 | 2019 | 27 | |
| 12 | 2012 | 26 | |
| 13 | 2002 | 24 | |
| 14 | 2011 | 21 | |
| 15 | 2017 | 20 | |
| 16 | 2009 | 20 | |
| 17 | 2022 | 17 | |
| 18 | 2018 | 17 | |
| 19 | 2021 | 14 | |
| 20 | 2022 | 14 |
About Ali Sak
Ali Sak is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cell Biology and Cancer Research, having authored 33 papers that have together received 917 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), Cancer Mechanisms and Therapy (4 papers), Cancer-related Molecular Pathways (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Chromatin Remodeling and Cancer (3 papers), Microtubule and mitosis dynamics (2 papers), Cancer therapeutics and mechanisms (2 papers) and Caveolin-1 and cellular processes (2 papers). The work is most often cited by research in Cancer Research (197 citations), Oncology (251 citations), Molecular Biology (574 citations), Radiology, Nuclear Medicine and Imaging (125 citations) and Genetics (48 citations). Ali Sak has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Martin Stuschke, Michael Groneberg, Christoph Pöttgen, Rainer Kehlbach, Markus Löbrich, Shaomeng Wang, Mahmoud Toulany, H. Peter Rodemann, Jianyong Chen and Sara Grehl. Their work appears in journals such as International Journal of Radiation Biology, Scientific Reports, Molecular Cancer Therapeutics, Cancers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.